Cargando…
Allosteric activation of the co-receptor BAK1 by the EFR receptor kinase initiates immune signaling
Transmembrane signaling by plant receptor kinases (RKs) has long been thought to involve reciprocal trans-phosphorylation of their intracellular kinase domains. The fact that many of these are pseudokinase domains, however, suggests that additional mechanisms must govern RK signaling activation. Non...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473708/ https://www.ncbi.nlm.nih.gov/pubmed/37662281 http://dx.doi.org/10.1101/2023.08.23.554490 |
_version_ | 1785100324022779904 |
---|---|
author | Mühlenbeck, Henning Tsutsui, Yuko Lemmon, Mark A. Bender, Kyle W. Zipfel, Cyril |
author_facet | Mühlenbeck, Henning Tsutsui, Yuko Lemmon, Mark A. Bender, Kyle W. Zipfel, Cyril |
author_sort | Mühlenbeck, Henning |
collection | PubMed |
description | Transmembrane signaling by plant receptor kinases (RKs) has long been thought to involve reciprocal trans-phosphorylation of their intracellular kinase domains. The fact that many of these are pseudokinase domains, however, suggests that additional mechanisms must govern RK signaling activation. Non-catalytic (pseudo)kinase signaling mechanisms have been described in metazoans, but information is scarce for plants. Recently, a non-catalytic function was reported for the leucine-rich repeat (LRR)-RK subfamily XIIa member EFR (ELONGATION FACTOR TU RECEPTOR) and phosphorylation-dependent conformational changes were proposed to regulate signaling of RKs with non-RD kinase domains. Here, using EFR as a model, we describe a non-catalytic activation mechanism for LRR-RKs with non-RD kinase domains. EFR is an active kinase, but a kinase-dead variant retains the ability to enhance catalytic activity of its co-receptor kinase BAK1/SERK3 (BRASSINOSTEROID INSENSITIVE 1-ASSOCIATED KINASE 1/SOMATIC EMBRYOGENESIS RECEPTOR KINASE 3). Applying hydrogen-deuterium exchange mass spectrometry (HDX-MS) analysis and designing homology-based intragenic suppressor mutations, we provide evidence that the EFR kinase domain must adopt its active conformation in order to activate BAK1 allosterically, likely by supporting αC-helix positioning in BAK1. Our results suggest a conformational toggle model for signaling, in which BAK1 first phosphorylates EFR in the activation loop to stabilize its active conformation, allowing EFR in turn to allosterically activate BAK1. |
format | Online Article Text |
id | pubmed-10473708 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cold Spring Harbor Laboratory |
record_format | MEDLINE/PubMed |
spelling | pubmed-104737082023-09-02 Allosteric activation of the co-receptor BAK1 by the EFR receptor kinase initiates immune signaling Mühlenbeck, Henning Tsutsui, Yuko Lemmon, Mark A. Bender, Kyle W. Zipfel, Cyril bioRxiv Article Transmembrane signaling by plant receptor kinases (RKs) has long been thought to involve reciprocal trans-phosphorylation of their intracellular kinase domains. The fact that many of these are pseudokinase domains, however, suggests that additional mechanisms must govern RK signaling activation. Non-catalytic (pseudo)kinase signaling mechanisms have been described in metazoans, but information is scarce for plants. Recently, a non-catalytic function was reported for the leucine-rich repeat (LRR)-RK subfamily XIIa member EFR (ELONGATION FACTOR TU RECEPTOR) and phosphorylation-dependent conformational changes were proposed to regulate signaling of RKs with non-RD kinase domains. Here, using EFR as a model, we describe a non-catalytic activation mechanism for LRR-RKs with non-RD kinase domains. EFR is an active kinase, but a kinase-dead variant retains the ability to enhance catalytic activity of its co-receptor kinase BAK1/SERK3 (BRASSINOSTEROID INSENSITIVE 1-ASSOCIATED KINASE 1/SOMATIC EMBRYOGENESIS RECEPTOR KINASE 3). Applying hydrogen-deuterium exchange mass spectrometry (HDX-MS) analysis and designing homology-based intragenic suppressor mutations, we provide evidence that the EFR kinase domain must adopt its active conformation in order to activate BAK1 allosterically, likely by supporting αC-helix positioning in BAK1. Our results suggest a conformational toggle model for signaling, in which BAK1 first phosphorylates EFR in the activation loop to stabilize its active conformation, allowing EFR in turn to allosterically activate BAK1. Cold Spring Harbor Laboratory 2023-08-24 /pmc/articles/PMC10473708/ /pubmed/37662281 http://dx.doi.org/10.1101/2023.08.23.554490 Text en https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/) , which allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. |
spellingShingle | Article Mühlenbeck, Henning Tsutsui, Yuko Lemmon, Mark A. Bender, Kyle W. Zipfel, Cyril Allosteric activation of the co-receptor BAK1 by the EFR receptor kinase initiates immune signaling |
title | Allosteric activation of the co-receptor BAK1 by the EFR receptor kinase initiates immune signaling |
title_full | Allosteric activation of the co-receptor BAK1 by the EFR receptor kinase initiates immune signaling |
title_fullStr | Allosteric activation of the co-receptor BAK1 by the EFR receptor kinase initiates immune signaling |
title_full_unstemmed | Allosteric activation of the co-receptor BAK1 by the EFR receptor kinase initiates immune signaling |
title_short | Allosteric activation of the co-receptor BAK1 by the EFR receptor kinase initiates immune signaling |
title_sort | allosteric activation of the co-receptor bak1 by the efr receptor kinase initiates immune signaling |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473708/ https://www.ncbi.nlm.nih.gov/pubmed/37662281 http://dx.doi.org/10.1101/2023.08.23.554490 |
work_keys_str_mv | AT muhlenbeckhenning allostericactivationofthecoreceptorbak1bytheefrreceptorkinaseinitiatesimmunesignaling AT tsutsuiyuko allostericactivationofthecoreceptorbak1bytheefrreceptorkinaseinitiatesimmunesignaling AT lemmonmarka allostericactivationofthecoreceptorbak1bytheefrreceptorkinaseinitiatesimmunesignaling AT benderkylew allostericactivationofthecoreceptorbak1bytheefrreceptorkinaseinitiatesimmunesignaling AT zipfelcyril allostericactivationofthecoreceptorbak1bytheefrreceptorkinaseinitiatesimmunesignaling |